Skip to main content
. 2020 Dec 18;23(7):1113–1124. doi: 10.1093/neuonc/noaa284

Table 3.

Demographics of Patients With a Clinical NF2 Diagnosis, Subdivided by Mode of Inheritance

Inheritance Type P Value
De Novo Constitutional, n (%) De Novo Mosaic, n (%) De Novo Unknown, n (%) Inherited, n (%)
Number 106 74 49 120 n/a
Female 46 (43.4) 47 (63.5) 29 (59.2) 59 (49.2) .037
Bilateral VS 104 (98.1) 55 (74.3) 38 (77.6) 109 (90.9) <.001
Median age diagnosis (y) 19 35 48 16 <.001
VS surgery/RTR in first 10 y 71 (67.0) 39 (52.7) 15 (30.6) 42 (34.7) <.001
Died 28 (26.4) 7 (9.5) 6 (12.2) 19 (15.8) .015
Died within 10 y 11 (10.4) 2 (2.7) 1 (2.0) 5 (4.1) .056
Mean age at death (y) 37.2 54.4 63.3 47.9 .003
Meningioma 61 (57.5) 39 (52.7) 20 (40.8) 46 (38.0) .018
Ependymoma 43 (40.6) 13 (17.6) 3 (6.1) 28 (23.3) <.001
Bevacizumab 25 (23.5) 5 (6.8) 1 (2.0) 27 (22.5) <.001
Meningioma surgery 24 (22.6) 10 (13.5) 4 (8.2) 15 (12.5) .063
Spinal surgery 21 (19.8) 11 (14.9) 3 (6.1) 13 (10.7) .085

Abbreviations: n, number; %, percentage; VS, vestibular schwannoma; RTR, radiotherapy-related.

Four disputed diagnoses have been removed.